Product Specifications Compound: CJC-1295 with DAC Class: Synthetic GHRH analog with albumin-binding modification Origin: Modified GHRH (1-29) analog with N-terminal Drug Affinity Complex Molecular Weight: ~3647 Da Form: Lyophilized powder Vial Size: 5mg in 3mL glass vial Purity: 99%+ verified by HPLC and mass spectrometry (See COAs) Research Background CJC-1295 with DAC has been investigated in research literature across several scientific contexts: GHRH receptor pharmacology investigations into receptor binding kinetics, signal transduction, and cellular response mechanisms in pituitary cell models Albumin-binding peptide research studies examining how covalent serum albumin binding via maleimidopropionic acid modification affects peptide half-life, distribution, and stability properties Peptide half-life engineering analytical chemistry research on extended-duration peptide analogs and the structural modifications that enable prolonged biological activity Comparative GHRH analog research studies positioning CJC-1295 with DAC alongside other modified GHRH peptides (including Sermorelin and Tesamorelin) in cellular research contexts Structure-activity relationships peptide chemistry research on how DAC modification affects receptor binding affinity compared to non-modified GHRH analogs Cellular signaling pathway research investigations into GHRH receptor activation and downstream cellular signaling cascades CJC-1295 with DAC was originally developed by ConjuChem Biotechnologies as part of their broader Drug Affinity Complex peptide research platform, which utilized albumin-binding chemistry to extend peptide half-life across multiple research compound development programs
8.3 Tissue distribution and half-life of curcumin The half-life of curcumin is a key parameter for understanding its pharmacokinetics
The rapid production of ROS in activated neutrophils, which requires increased pentose cycling, and thus increased G6PD activity, acts to promote NETosis via oxidative inhibition of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) ( Overall, the uniquely rapid need for neutrophil effector functions, such as NETosis, phagocytosis and degranulation, to be mobilized quickly in the innate immune response necessitates brisk production of NADPH, which is chiefly controlled by the PPP rate-limiting activity of G6PD
The PrepTide: Disclaimer
Hot cht ca cy k sa c kh nng tng mc glutathione t nhin nh vo hot cht silymarin c c tnh chng oxy ha mnh
